mTOR REGULATES TAU PHOSPHORYLATION AND DEGRADATION: IMPLICATIONS FOR ALZHEIMER’S DISEASE AND OTHER TAUOPATHIES

Documenti analoghi

• Genetically reducing mTOR signaling rescues central insulin dysregulation in a mouse model of Alzheimer’s disease
  di: Caccamo, Antonella, et al.
  Pubblicazione: (2018)
• Molecular Interplay between Mammalian Target of Rapamycin (mTOR), Amyloid-β, and Tau: EFFECTS ON COGNITIVE IMPAIRMENTS
  di: Caccamo, Antonella, et al.
  Pubblicazione: (2010)
• The role of mTOR signaling in Alzheimer disease
  di: Oddo, Salvatore
  Pubblicazione: (2012)
• Naturally Secreted Amyloid-β Increases Mammalian Target of Rapamycin (mTOR) Activity via a PRAS40-mediated Mechanism
  di: Caccamo, Antonella, et al.
  Pubblicazione: (2011)
• Tau Ser208 phosphorylation promotes aggregation and reveals neuropathologic diversity in Alzheimer’s disease and other tauopathies
  di: Yuxing Xia, et al.
  Pubblicazione: (2020-06-01)